National Taiwan University Hospital

www.ntuh.gov.tw/default.aspx
Taipei, Taiwan

The National Taiwan University Hospital started operations under Japanese rule in Daitōtei on June 18, 1895, and moved to its present location in 1898. The Hospital was later annexed to the Medical School of Taihoku Imperial University and renamed Taihoku Imperial University Medical School Affiliated Hospital in 1937. The present name was adopted after the Republic of China took over the hospital upon Taiwan's retrocession in 1945.On October 19, 1991, the completion of a large new building complex on the so-called East Site marked another milestone in the history of the NTUH. Today, the East and West Sites together have more than 4,000 employees, serving 2,000 inpatients and 8,000 outpatients daily. The hospital remains the best-known and most highly renowned medical center in Taiwan.The hospital is a world-renowned medical center for liver diseases. Advanced surgical, angiographical, and endoscopic procedures are routinely performed. Wikipedia.


Time filter

Source Type

Patent
National Tsing Hua University, National Taiwan University Hospital and National Taiwan University | Date: 2015-12-03

An image analysis method and an apparatus thereof for assessment of PD (peritoneal dialysis) complications in peritoneal dialysis are provided. An analysis procedure is executed on an image under test of a dialysis bag, so as to obtain a color location in a color space corresponding to the image under test. A prompt signal is sent when the color locations obtained in a time period gradually become close to a disease warning range after executing the analysis procedure on a plurality of images under test.


Patent
National Taiwan University Hospital | Date: 2016-05-05

The present invention provides a method of calculating an average moment arm row by row, comprising measuring the pressure an object exerts on a pressure sensor matrix, obtaining the pressure values and moment arms for each sensor of the sensor matrix in a time sequence, and calculating an average moment arm for each row of the sensor matrix, to reveal a row of sensors whose pressure is distributed farthest from or closest to the reference axis over time. The present invention also provides a method of calculating a percentage of average moment arm row by row to reveal the relative pressure distribution in a row between the sensors sensing pressure closest to and farthest from the reference axis. The present invention further provides a method of calculating a change of average moment arm and a change of percentage of average moment arm over time row by row.


Patent
National Chiao Tung University and National Taiwan University Hospital | Date: 2015-12-31

A sensing bone fixing element includes a fixing portion, a fastening portion, a capacitor structure, and a coil. The fastening portion is fixed to the fixing portion and suitable for being fastened to a bone. The fastening portion passes through the capacitor structure which has a capacitance value and includes a first conductive layer, a second conductive layer, and an elastic dielectric layer. The first conductive layer leans against the fixing portion, the second conductive layer leans against the bone, and the elastic dielectric layer is located between the first conductive layer and the second conductive layer. The coil has an inductance value, and two ends of the coil are respectively connected to the first conductive layer and the second conductive layer. The coil receives a detection radio frequency (RF) signal and generates a responding RF signal according to variations in the capacitance value and the inductance value.


Patent
National Tsing Hua University, National Taiwan University and National Taiwan University Hospital | Date: 2016-04-18

A tele-care management system for peritoneal dialysis (PD) includes at least a container, a holder, a removable detection device and a mobile device. The container is for placing effluent fluid of peritoneal dialysis. The holder is for placing the container. The removable detection device includes a detection unit, a processor and a communication interface, wherein the processor detects the turbidity and the chrominance of the effluent fluid and performs a quantitative analysis on the effluent fluid, and generates a turbidity prediction value based on the detection result of the detection unit. The processor respectively calculates first and second turbidity values, which correspond to first and second turbidity respectively, for the effluent fluid according to first and second algorithms and selects one from the first and second turbidity values to generate the turbidity prediction value based on a predetermined threshold value sent to a mobile device for further processing.


Patent
Industrial Technology Research Institute of Taiwan and National Taiwan University Hospital | Date: 2016-07-15

According to embodiments, a membrane with a flat or curved surface is provided for protection of intraocular tissues. The membrane can be used to cover the cornea for protecting corneal endothelial cells, to cover the anterior and posterior surface of the iris, or to cover the surface of the posterior capsule for separating the intraocular tissues. The membrane has a layered structure, which is composed of a collagen and a hydrophilic biopolymer or an organic polymer material. In particular, the membrane has high transparency and high water retention in a wet state.


Patent
National Taiwan University and National Taiwan University Hospital | Date: 2014-12-02

The present invention provides an implant for pelvic organ prolapse support, comprising an implant for anterior vaginal wall prolapse support which comprises first body having a first angle and a second angle, a pair of first arms and a pair of second arms. The implant for pelvic organ prolapse support of the present invention can treat cystocele and stress urinary incontinence simultaneously, and can optionally combine with an implant for posterior vaginal wall prolapse support and an auxiliary supporter to treat cystocele, stress urinary incontinence, enterocele, uterine prolapse, rectocele prolapse, anal prolapse, and vaginal vault prolapse at one time.


Patent
National Taiwan University, National Taiwan University Hospital and Wo Andrew Man | Date: 2017-02-22

The present invention provides an implant for pelvic organ prolapse support, comprising an implant for anterior vaginal wall prolapse support which comprises first body having a first angle and a second angle, a pair of first arms and a pair of second arms. The implant for pelvic organ prolapse support of the present invention can treat cystocele and stress urinary incontinence simultaneously, and can optionally combine with an implant for posterior vaginal wall prolapse support and an auxiliary supporter to treat cystocele, stress urinary incontinence, enterocele, uterine prolapse, rectocele prolapse, anal prolapse, and vaginal vault prolapse at one time.


Patent
Industrial Technology Research Institute of Taiwan and National Taiwan University Hospital | Date: 2016-12-14

A radiofrequency ablation electrode needle includes at least one first segment and at least two second segments. The at least one first segment and the at least two second segments are exposed on a surface of the needle body. An impedance of the at least one first segment is smaller than an impedance of the at least two second segments and at least one of the at least one first segment is disposed between two immediately adjacent ones of the at least two second segments. Besides, the radiofrequency ablation electrode needle is a monopolar electrode needle.


Tseng C.-H.,National Taiwan University Hospital
Diabetologia | Year: 2011

Aims/hypothesis: Studies on the link between diabetes and bladder cancer in Asians are rare. We investigated the association between diabetes and incidence of bladder cancer by using a large national insurance database. Methods: A random sample of 1,000,000 individuals covered by the National Health Insurance was recruited. A total of 495,199 men and 503,748 women for all ages and 187,609 men and 189,762 women ≥40 years old and without bladder cancer at recruitment were followed from 2003 to 2005. Cox regression evaluated the adjusted relative risk for all ages and for age ≥40 years old. Results: The results were similar for all ages and for age ≥40 years. In Cox models, patients with diabetes consistently showed a significantly higher relative risk ranging from 1.36 to 1.51 after adjustment for age, sex and other potential confounders. Age, male sex, nephropathy, urinary tract diseases (infection and stone) and statin use were associated with bladder cancer, but occupation, hypertension, stroke, ischaemic heart disease, peripheral arterial disease, eye disease, dyslipidaemia and medications (oral glucose-lowering agents including sulfonylurea, metformin, acarbose and thiazolidinediones, insulin, fibrates, ACE inhibitors/angiotensin receptor blockers and calcium channel blockers) were not. Chronic obstructive pulmonary disease and living in regions other than Metropolitan Taipei were associated with lower risk. Conclusions: Patients with diabetes have a higher risk of bladder cancer. The association with urinary tract diseases suggests a complex scenario in the link between bladder cancer and diabetes at different disease stages. © 2011 Springer-Verlag.


Alterations of galectin-3 expression are often seen in cancers and may contribute to tumorigenesis, cancer progression, and metastasis. The studies concerning clinical implications of galectin-3 expression in patients with acute myeloid leukemia (AML) are scarce. We investigated the expression of LGALS3, the gene encoding galectin-3, in the bone marrow (BM) mononuclear cells from an original cohort comprising 280 adults with primary non-acute promyelocytic leukemia. Higher LGALS3 expression was closely associated with older age, French-American-British M4/M5 subtypes, CD14 expression on leukemic cells, and PTPN11 mutation, but negatively correlated with CEBPA mutation and FLT3-ITD. Compared with patients with lower LGALS3 expression, those with higher expression had lower complete remission rates, higher primary refractory rates, and shorter overall survival. This result was validated in an independent validation cohort. A scoring system incorporating higher LGALS3 expression and 8 other risk factors, including age, white blood cell count, cytogenetics, and gene mutations, into survival analysis proved to be very useful to stratify patients with AML into different prognostic groups (P < .001). In conclusion, BM LGALS3 expression may serve as a new biomarker to predict clinical outcome in patients with AML, and galectin-3 may serve as a potential therapeutic target in those patients with higher expression of this protein.

Loading National Taiwan University Hospital collaborators
Loading National Taiwan University Hospital collaborators